Formulation Development Outsourcing Market Report 2026

(MENAFN- GlobeNewsWire - Nasdaq) The formulation development outsourcing market offers opportunities driven by increasing pharmaceutical R&D complexity, demand for biologics, and personalized medicine. Notable trends include AI-powered generative platforms and rising outsourcing of complex drug formulations. Enhanced regulatory compliance fosters growth.

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Formulation Development Outsourcing Market Report 2026" has been added to ResearchAndMarkets's offering.

The formulation development outsourcing market is poised for dynamic growth, forecasted to expand from $32.32 billion in 2025 to $35.45 billion in 2026 at a 9.7% CAGR. This surge is driven by complex pharmaceutical R&D, more drug candidates, specialized expertise demands, and heightened regulatory scrutiny. By 2030, the market is expected to reach $53.3 billion, driven by the rising demand for biologics, personalized medicine, and advanced formulation technologies, maintaining a CAGR of 10.7%.

The industry is witnessing a shift towards the outsourcing of complex drug formulations, adopting quality by design (QbD) approaches, and a growing need for injectable and specialized dosage forms. Companies are expanding scale-up and technology transfer services to maintain regulatory compliance and meet accelerated time-to-market demands.

The upward trend in drug demand, underscored by a 13.5% increase in EU exports of medicinal products in 2024, is fueling market growth. Formulation development outsourcing is essential in biopharmaceutical development, enhancing drug delivery systems and offering cost-effective solutions for pharmaceutical firms.

Innovative solutions, like AI-powered generative cloud platforms, are transformative for the industry. Such platforms expedite molecular design, drug discovery, and other R&D functions. NVIDIA's BioNeMo Cloud, launched in 2023, exemplifies this innovation, offering pre-trained AI models for research acceleration. This service is already adopted by leaders like Amgen to drive efficient, data-driven innovation.

In April 2024, CoreRx, Inc. acquired Societal CDMO Inc., enhancing its capabilities in formulation development and scale-up manufacturing to better serve pharmaceutical clients. This acquisition supports CoreRx's strategy to offer integrated development-to-commercial manufacturing services.

Key players in this thriving market include Syngene International Ltd., Aizant Drug Research Solutions, Catalent Inc., Intertek Group plc, Recipharm AB, and many others. These companies are central to the market's expansion, offering critical services like ingredient sourcing, stability studies, and regulatory support.

North America led the global market in 2025, with major regions such as Asia-Pacific, Europe, and Africa also seeing significant activity. The market's revenues are generated from direct sales, grants, and more, focused on service provision instead of resales. With a continual push towards innovation and efficiency in drug development processes, the formulation development outsourcing market stands as a cornerstone of the global pharmaceutical landscape.

Key Attributes:

Report Attribute	Details
No. of Pages	250
Forecast Period	2026 - 2030
Estimated Market Value (USD) in 2026	$35.45 Billion
Forecasted Market Value (USD) by 2030	$53.3 Billion
Compound Annual Growth Rate	10.7%
Regions Covered	Global

Major Trends

• Increasing Outsourcing of Complex Drug Formulations
• Rising Adoption of Quality by Design Approaches
• Growing Demand for Injectable and Specialized Dosage Forms
• Expansion of Scale-Up and Technology Transfer Services
• Enhanced Focus on Regulatory-Compliant Formulation Development

Companies Featured

• Syngene International Ltd.
• Aizant Drug Research Solutions Private Limited.
• Catalent Inc.
• Intertek Group PLC
• Recipharm AB
• SGS S.A.
• Lonza Group AG
• Eurofins Scientific SE
• Laboratory Corporation of America Holdings
• Charles River Laboratories International Inc.
• Piramal Pharma Limited.
• Quotient Sciences Ltd.
• Almac Group
• Patheon
• Evonik Industries AG
• Metrics Contract Services
• Aenova Group
• Fareva Group
• Vetter Pharma International GmbH
• Aesica Pharmaceuticals
• WuXi AppTec
• Formosa Laboratories Inc.
• Aptuit LLC
• ProPharma Group
• Laurus Labs Limited

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Formulation Development Outsourcing Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN11052026004107003653ID1111097669